Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Taysha Gene Therapies Inc (TSHA)

Taysha Gene Therapies Inc (TSHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Taysha Gene Therapies Inc 3000 Pegasus Park Dr. Ste 1430 DALLAS TX 75247 USA

www.tayshagtx.com P: 214-612-0000

Description:

Taysha Gene Therapies Inc. is a patient-centric gene therapy company. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system. The company's product pipeline includes TSHA-101, TSHA-118, TSHA-102, TSHA-103 and TSHA-104 which are in clinical stage. Taysha Gene Therapies Inc. is based in Dallas, Texas.

Key Statistics

Overview:

Market Capitalization, $K 480,636
Enterprise Value, $K 376,756
Shares Outstanding, K 187,018
Annual Sales, $ 15,450 K
Annual Net Income, $ -111,570 K
Last Quarter Sales, $ 3,600 K
Last Quarter Net Income, $ 47,740 K
EBIT, $ -71,370 K
EBITDA, $ -70,000 K
60-Month Beta 0.37
% of Insider Shareholders 2.70%
% of Institutional Shareholders 77.70%
Float, K 181,969
% Float 97.30%
Short Volume Ratio 0.66

Growth:

1-Year Return 280.80%
3-Year Return -87.88%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.35 on 03/19/24
Latest Earnings Date 05/09/24 [--]
Earnings Per Share ttm -0.44
EPS Growth vs. Prev Qtr 369.23%
EPS Growth vs. Prev Year 135.35%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

TSHA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -55.72%
Profit Margin % -722.14%
Debt/Equity 0.54
Price/Sales 31.23
Price/Cash Flow N/A
Price/Book 6.04
Book Value/Share 0.40
Interest Coverage -21.31
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar